Skip to main content
FinSpry Logo
FinSpry
AVTX logo
AVTX
(NASDAQ)
Avalo Therapeutics, Inc.
$19.71-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Avalo Therapeutics (AVTX) Stock Price & Financial Analysis

Avalo Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$18.95 - $20.49
52-Week High$24.27
52-Week Low$9.54
Open$19.01
Volume779.34K
Average Volume (3M)757.84K
Market Cap386.66M
Shares Outstanding20.11M
Price to Sales (P/S)6553.49
Price to Book (P/B)5.66
EV/EBITDA-4.32
Revenue (TTM)59.00K
Net Income (TTM)-84.74M
Free Cash Flow (TTM)-59.69M
EPS (TTM)$-5.34
Profit Margin-143627.12%
Operating Margin-134164.41%
Return on Equity (ROE)-124.03%
Debt to Equity0.03
50-Day MA$19.14
200-Day MA$16.93
52-Week Change72.74%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Avalo Therapeutics

What is the current stock price for AVTX?

As of the latest trading session, AVTX stock trades at $19.71. The 52-week range is $9.54–$24.27, with a day range of $18.95–$20.49.

What is the P/E ratio for AVTX?

The P/E ratio (Price-to-Earnings) for AVTX is shown in the Key Statistics section. This valuation metric helps compare Avalo Therapeutics, Inc. to industry peers.

Does AVTX pay dividends?

Avalo Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AVTX?

Based on 3 analysts, the consensus for AVTX is Buy.

What is the market cap of AVTX?

Avalo Therapeutics's market capitalization is $396.3M, classifying it as a small-cap company. Avalo Therapeutics operates in the Healthcare sector within the Biotechnology industry.